1. Home
  2. CABA vs TCX Comparison

CABA vs TCX Comparison

Compare CABA & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • TCX
  • Stock Information
  • Founded
  • CABA 2017
  • TCX 1992
  • Country
  • CABA United States
  • TCX Canada
  • Employees
  • CABA N/A
  • TCX N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • TCX EDP Services
  • Sector
  • CABA Health Care
  • TCX Technology
  • Exchange
  • CABA Nasdaq
  • TCX Nasdaq
  • Market Cap
  • CABA 157.4M
  • TCX 220.5M
  • IPO Year
  • CABA 2019
  • TCX 1996
  • Fundamental
  • Price
  • CABA $1.54
  • TCX $21.20
  • Analyst Decision
  • CABA Strong Buy
  • TCX
  • Analyst Count
  • CABA 7
  • TCX 0
  • Target Price
  • CABA $14.43
  • TCX N/A
  • AVG Volume (30 Days)
  • CABA 2.9M
  • TCX 35.8K
  • Earning Date
  • CABA 08-07-2025
  • TCX 08-07-2025
  • Dividend Yield
  • CABA N/A
  • TCX N/A
  • EPS Growth
  • CABA N/A
  • TCX N/A
  • EPS
  • CABA N/A
  • TCX N/A
  • Revenue
  • CABA N/A
  • TCX $369,427,000.00
  • Revenue This Year
  • CABA N/A
  • TCX N/A
  • Revenue Next Year
  • CABA N/A
  • TCX N/A
  • P/E Ratio
  • CABA N/A
  • TCX N/A
  • Revenue Growth
  • CABA N/A
  • TCX 6.66
  • 52 Week Low
  • CABA $0.99
  • TCX $13.27
  • 52 Week High
  • CABA $8.77
  • TCX $26.48
  • Technical
  • Relative Strength Index (RSI)
  • CABA 42.63
  • TCX 68.93
  • Support Level
  • CABA $1.43
  • TCX $20.15
  • Resistance Level
  • CABA $1.68
  • TCX $20.63
  • Average True Range (ATR)
  • CABA 0.12
  • TCX 0.58
  • MACD
  • CABA -0.03
  • TCX 0.04
  • Stochastic Oscillator
  • CABA 27.78
  • TCX 81.15

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

Share on Social Networks: